Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Paul A. Basciano"'
Autor:
James B. Bussel, Christina S. Lee, Caroline Seery, Allison A. Imahiyerobo, Michaela V. Thompson, Diane Catellier, Ithamar G. Turenne, Vivek L. Patel, Paul A. Basciano, Rebecca L. Elstrom, Waleed Ghanima
Publikováno v:
Haematologica, Vol 99, Iss 7 (2014)
Adults with newly diagnosed or persistent immunothrombocytopenia frequently relapse upon tapering steroids; adults and children with chronic disease have an even lower likelihood of lasting response. In adults with newly-diagnosed immunothrombocytope
Externí odkaz:
https://doaj.org/article/dd973c372da54747bccd9909177e8fe5
Autor:
Caroline Seery, Waleed Ghanima, Diane Catellier, Christina S. Lee, Paul A. Basciano, Michaela V. Thompson, Allison A. Imahiyerobo, Vivek Patel, James B. Bussel, Ithamar G. Turenne, Rebecca Elstrom
Publikováno v:
Haematologica. 99:1264-1271
Adults with newly diagnosed or persistent immunothrombocytopenia frequently relapse upon tapering steroids; adults and children with chronic disease have an even lower likelihood of lasting response. In adults with newly-diagnosed immunothrombocytope
Autor:
Jason J. Luke, Josep Tabernero, Anthony Joshua, Jayesh Desai, Andrea I. Varga, Victor Moreno, Carlos A. Gomez-Roca, Ben Markman, Filippo G. De Braud, Sandip Pravin Patel, Matteo S. Carlino, Lillian L. Siu, Giuseppe Curigliano, Zhaohui Liu, Yuko Ishii, Megan Wind-Rotolo, Paul Andrew Basciano, Alex Azrilevich, Karen A. Gelmon
Publikováno v:
Journal of Clinical Oncology. 37:358-358
358 Background: Nivo (antiPD-1) has shown durable responses and manageable safety (ORR, 19.6%; grade 3‒4 treatment-related AEs [TRAEs], 18%) in advBC (Sharma et al. Lancet Oncol 2017), but prolonging survival in more pts requires additional appro
Publikováno v:
British Journal of Haematology. 160:237-243
Predictive biomarkers are needed in immune thrombocytopenia (ITP). Single nucleotide polymorphisms (SNPs) in beta 1 tubulin are potential candidates, as beta 1 tubulin is integral for platelet production and function, and SNPs in beta 1 tubulin have
Autor:
Rodney Williams, N. Petruzzi, B. Stewart, C. Fox, D. Tacelosky, Paul A. Basciano, K. Klinger, James R. Sellers, C. King Smith, P. Damiani, E. L. McNeil, C. Osborn, S. Deacon, B. Biallas
Publikováno v:
Cell Motility and the Cytoskeleton. 58:71-82
Melanosomes (pigment granules) within retinal pigment epithelial (RPE) cells of fish and amphibians undergo massive migrations in response to light conditions to control light flux to the retina. Previous research has shown that melanosome motility w
Autor:
Monica L. Guzman, Paraskevi Giannakakou, Siddhartha Sen, Silvana Di Giandomenico, Jason Matakas, Yang Bai, Paul A. Basciano, Todd Evans, Xi Li, Joseph M. Scandura
Publikováno v:
Cancer Research. 77:4646-4646
The αβ-tubulin dimer is the building block of the microtubule cytoskeleton, which is important for many cellular functions. Several α and β tubulin isotypes have been identified so far; Hβ-1 tubulin (human β tubulin Class VI) is a hematopoietic
Publikováno v:
Blood. 123(23)
The existence of spontaneous heparin-induced thrombocytopenia (HIT) syndrome (or autoimmune HIT), defined as a transient prothrombotic thrombocytopenic disorder without proximate heparin exposure serologically indistinguishable from HIT, is controver
Publikováno v:
Pigment Cell Research. 14:14-22
The retinal pigment epithelium (RPE) of teleosts contains pigment granules that migrate in response to changes in light condition. Dissociated, cultured RPE cells in vitro can be triggered to aggregate or disperse pigment granules by the application
Autor:
Mary Ann Howland, Lewis S. Nelson, Paul A. Basciano, Silas W. Smith, Betty C. Chen, Robert S. Hoffman, Fiona M. Garlich, Aaron D. Viny
Publikováno v:
Clinical toxicology (Philadelphia, Pa.). 50(9)
Dabigatran is a direct thrombin inhibitor approved for anticoagulation in non-valvular atrial fibrillation and, in some countries, for thromboembolism prophylaxis following select orthopedic surgeries. Despite decreased rates of thromboembolism, blee
Autor:
James B. Bussel, Paul A. Basciano
Publikováno v:
Current opinion in hematology. 19(5)
Purpose of review Thrombopoietin-receptor agonists (TPO-RAs) have been approved for use in immune thrombocytopenia (ITP) after showing safety and efficacy. There is increasing interest to expand the role of TPO-RAs, both in ITP as well as in other th